http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020102252-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a355b8e930b2c5b85d705d6f9f335a5 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2019-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d8dba73baf1223fd21412b76c1d5a6b |
| publicationDate | 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2020102252-A1 |
| titleOfInvention | Cancer screening and therapeutics |
| abstract | The invention herein generally relates to early stage cancer screening and therapeutics, and particular methods of detecting and treating lung cancer. The invention identifies one or more mutations in genes, such as 15- HPGD. This can be done after collecting any suitable biological sample from the patient, such as their fingernail, saliva or blood. After collection, DNA is isolated/extracted and analyzed using a gene sequencing method. The gene sequencing method will detect predetermined one or more mutations inside this single gene's base pairs caused by the cancer, such as mutations created from an incremented drop in oxygen caused by the cancer cells (a bi-product mutation) and/or mutations that fail to suppress tumor growth for cancer. By blocking biological pathways associated with the bi-product mutation, the growth of the tumor can be reduced or prevented thereby improving prognosis |
| priorityDate | 2018-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.